Prostate cancer remains one of the most prevalent cancers among men. In Switzerland, the demand for advanced, non-invasive treatment methods continues to grow. Sonablate® HIFU (High-Intensity Focused Ultrasound) represents a cutting-edge solution, offering effective treatment while preserving quality of life. Learn more on the official page here.
Table of Contents
- What is Sonablate® HIFU?
- Advantages of HIFU Therapy
- Application in Swiss Medical Centers
- Procedure and Recovery
- Patient Eligibility
- Treatment Costs
- Conclusion
What is Sonablate® HIFU?
Sonablate® HIFU is a medical device that uses high-frequency ultrasound waves to ablate targeted prostate tissue with precision. This technique allows for the destruction of cancerous areas while minimizing damage to surrounding healthy tissues.
Advantages of HIFU Therapy
- Minimally Invasive: No incisions required, reducing the risk of infection and blood loss.
- Precision Treatment: Real-time imaging ensures accurate targeting of cancerous tissue.
- Outpatient Procedure: Most patients return home the same day.
- Low Risk of Side Effects: Lower incidence of urinary incontinence and sexual dysfunction compared to surgery.
- Repeatable: HIFU can be repeated if necessary, or followed by other treatments.
Application in Swiss Medical Centers
Several leading Swiss hospitals and urology centers now offer Sonablate® HIFU, making it accessible to patients across the country. The technology meets high Swiss medical standards and is supported by experienced urologists and radiologists.
Procedure and Recovery
The HIFU treatment typically lasts 1–2 hours. Patients are administered spinal or general anesthesia. During the procedure, a transrectal probe emits focused ultrasound waves that heat and destroy targeted tissue. Recovery time is minimal, and patients often resume normal activities within a few days.
Patient Eligibility
Sonablate® HIFU is most suitable for:
- Patients with localized prostate cancer.
- Men seeking to avoid radical prostatectomy or radiation therapy.
- Individuals for whom active surveillance is no longer appropriate.
- Patients experiencing recurrence after radiation therapy.
Treatment Costs
In Switzerland, the cost of Sonablate® HIFU varies depending on the clinic and patient condition, generally ranging between CHF 12,000 and CHF 18,000. Some private insurance plans may reimburse part of the treatment, but prior authorization is recommended.
Conclusion
Sonablate® HIFU offers Swiss patients an innovative, effective, and minimally invasive alternative to traditional prostate cancer treatments. With high precision and fewer complications, it represents a significant step forward in personalized cancer care.
